Metastatic Renal Cell Carcinoma Clinical Trials

ReadTheTrial indexes 3 studies for Metastatic Renal Cell Carcinoma. The most common development stage is Phase 3 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

3 clinical trials found for Metastatic Renal Cell Carcinoma.

Pipeline by Phase

PhaseTrialsDistribution
Phase 3 1
33%
Phase 2 1
33%
Phase 1 1
33%

Trial Status Breakdown

Trials for Metastatic Renal Cell Carcinoma

Phase III Randomized Trial of Stereotactic Ablative Radiotherapy (SAbR) for Oligometastatic Advanced Renal Carcinoma (SOAR)

NCT05863351 · ACTIVE NOT RECRUITING · Phase 3

Randomized Phase II Stereotactic Ablative Radiation Therapy (SABR) for Metastatic Unresected Renal Cell Carcinoma (RCC) Receiving Immunotherapy (SAMURAI)

NCT05327686 · RECRUITING · Phase 2

A Dose-escalation Phase I Trial of PD-1 Knockout Engineered T Cells for the Treatment of Metastatic Renal Cell Carcinoma

NCT02867332 · WITHDRAWN · Phase 1

Frequently Asked Questions

What clinical trials are available for Metastatic Renal Cell Carcinoma?

There are 3 clinical trials listed for Metastatic Renal Cell Carcinoma. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Metastatic Renal Cell Carcinoma trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Metastatic Renal Cell Carcinoma trials in?

Current Metastatic Renal Cell Carcinoma trials are distributed across: Phase 3 (1), Phase 2 (1), Phase 1 (1).

Find More Trials